Surgical Robotic Systems Market by Component (Systems, Accessories and Services), and Surgery Type (Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery and Other Surgeries): Global Opportunity Analysis and Industry Forecast up to 2027
The surgical robotic systems market refers to the market for advanced robotic technologies used in surgical procedures. These systems are designed to assist surgeons in performing minimally invasive surgeries with enhanced precision, control, and visualization. Minimally invasive surgeries (MIS) have gained popularity due to their advantages over traditional open surgeries, such as reduced pain, shorter hospital stays, faster recovery, and fewer complications. One of the significant factors majorly driving the market is augmenting demand for minimally invasive procedures among people. The surgical robotic systems enable surgeons to perform minimally invasive procedures with higher precision and control, making them a preferred choice for both patients and healthcare providers. The Surgical Robotic Systems Market is likely to grow at a rate of 14.6% CAGR by 2027.
Surgical robotic systems market by Component
Systems
Accessories & Instrument
Services
Surgical robotic systems market by Surgery type
Gynecology Surgery
Urology Surgery
Neurosurgery
Orthopedic Surgery
General Surgery
Surgical robotic systems Market by Geography
North America
Europe
Asia Pacific
Rest of the World
Here is an overview of the key aspects of the surgical robotic systems market:
As per market by component the accessories segment dominated the global surgical robotics market. This is due to the increased usage of accessories per surgical procedure. Further, the accessories are replaced after each surgical procedure, thus leading to the market revenue.
In the market for surgery type the orthopedic surgery holds a dominant position in the market. This is attributed to the increase in orthopedic injuries worldwide.
Robotic-Assisted Surgeries: Surgical robotic systems enable surgeons to perform complex procedures with the assistance of robotic arms and instruments. These systems offer greater dexterity and range of motion compared to traditional surgical instruments, allowing for more precise movements and improved access to anatomical structures. Robotic assistance can be utilized in various surgical specialties, including urology, gynecology, general surgery, cardiothoracic surgery, and orthopedics.
Da Vinci Surgical System: The most well-known and widely used surgical robotic system is the da Vinci Surgical System, developed by Intuitive Surgical. This system consists of robotic arms, a high-definition 3D visualization system, and specialized surgical instruments. The surgeon controls the system from a console, translating their hand movements into precise actions by the robotic arms. The da Vinci Surgical System has been adopted in many hospitals globally and has facilitated numerous minimally invasive procedures.
Advantages of Robotic Surgery: Robotic-assisted surgeries offer several advantages over traditional open surgeries and laparoscopic procedures. These include smaller incisions, reduced blood loss, shorter hospital stays, faster recovery times, and potentially less post-operative pain. The improved visualization and instrument maneuverability provided by robotic systems can contribute to enhanced surgical outcomes and patient satisfaction.
Market Growth and Technological Advancements: The surgical robotic systems market has been experiencing steady growth. Technological advancements, such as improved robotic arm articulation, better imaging capabilities, and enhanced software interfaces, have expanded the applications and capabilities of robotic surgery. Additionally, the development of smaller and more portable robotic systems is making robotic-assisted surgeries accessible to a broader range of healthcare facilities.
Challenges and Opportunities: Despite the benefits, there are challenges associated with surgical robotic systems, including high initial costs, ongoing maintenance expenses, and the learning curve for surgeons adopting the technology. However, as more surgeons gain experience and the costs of robotic systems decrease over time, the adoption rate is expected to increase. There are also opportunities for further innovation, such as the integration of artificial intelligence, machine learning, and augmented reality into surgical robotic systems, which could further enhance surgical precision and outcomes.
The major leading companies of the herpes simplex virustreatment market are INTUITIVE SURGICAL, INC., GLOBUS MEDICAL, INC, Johnson & Johnson, Medtronic Plc., Siemens AG (Siemens Healthineers), Smith & Nephew, Stryker Corporation, Titan Medical Inc., Transenterix, Inc., Zimmer Biomet Holdings, Inc.
The surgical robotic systems market is expected to continue growing as advancements in technology, increasing surgical expertise, and expanding applications drive adoption. The focus on minimally invasive procedures, improved patient outcomes, and the demand for precision and efficiency in surgeries contribute to the market's expansion.
Anexclusive analysis of all key geographical regions is included in the report which determines the potential opportunities in these regions.
Detailed information about the attributes which are generating growth in the herpes simplex virus treatment market in the forecast period.
Anexactestimation of the herpes simplex virus treatmentmarket share and its contribution to the parent market is provided in the report.
Further profiles of leading competitors and their dynamic strategies are also covered in thestudy.
Surgical robotic systems market by Component
Systems
Accessories & Instrument
Services
Surgical robotic systems market by Surgery type
Gynecology Surgery
Urology Surgery
Neurosurgery
Orthopedic Surgery
General Surgery
Surgical robotic systems Market by Geography
North America
Europe
Asia Pacific
Rest of the World
Here is an overview of the key aspects of the surgical robotic systems market:
As per market by component the accessories segment dominated the global surgical robotics market. This is due to the increased usage of accessories per surgical procedure. Further, the accessories are replaced after each surgical procedure, thus leading to the market revenue.
In the market for surgery type the orthopedic surgery holds a dominant position in the market. This is attributed to the increase in orthopedic injuries worldwide.
Robotic-Assisted Surgeries: Surgical robotic systems enable surgeons to perform complex procedures with the assistance of robotic arms and instruments. These systems offer greater dexterity and range of motion compared to traditional surgical instruments, allowing for more precise movements and improved access to anatomical structures. Robotic assistance can be utilized in various surgical specialties, including urology, gynecology, general surgery, cardiothoracic surgery, and orthopedics.
Da Vinci Surgical System: The most well-known and widely used surgical robotic system is the da Vinci Surgical System, developed by Intuitive Surgical. This system consists of robotic arms, a high-definition 3D visualization system, and specialized surgical instruments. The surgeon controls the system from a console, translating their hand movements into precise actions by the robotic arms. The da Vinci Surgical System has been adopted in many hospitals globally and has facilitated numerous minimally invasive procedures.
Advantages of Robotic Surgery: Robotic-assisted surgeries offer several advantages over traditional open surgeries and laparoscopic procedures. These include smaller incisions, reduced blood loss, shorter hospital stays, faster recovery times, and potentially less post-operative pain. The improved visualization and instrument maneuverability provided by robotic systems can contribute to enhanced surgical outcomes and patient satisfaction.
Market Growth and Technological Advancements: The surgical robotic systems market has been experiencing steady growth. Technological advancements, such as improved robotic arm articulation, better imaging capabilities, and enhanced software interfaces, have expanded the applications and capabilities of robotic surgery. Additionally, the development of smaller and more portable robotic systems is making robotic-assisted surgeries accessible to a broader range of healthcare facilities.
Challenges and Opportunities: Despite the benefits, there are challenges associated with surgical robotic systems, including high initial costs, ongoing maintenance expenses, and the learning curve for surgeons adopting the technology. However, as more surgeons gain experience and the costs of robotic systems decrease over time, the adoption rate is expected to increase. There are also opportunities for further innovation, such as the integration of artificial intelligence, machine learning, and augmented reality into surgical robotic systems, which could further enhance surgical precision and outcomes.
The major leading companies of the herpes simplex virustreatment market are INTUITIVE SURGICAL, INC., GLOBUS MEDICAL, INC, Johnson & Johnson, Medtronic Plc., Siemens AG (Siemens Healthineers), Smith & Nephew, Stryker Corporation, Titan Medical Inc., Transenterix, Inc., Zimmer Biomet Holdings, Inc.
The surgical robotic systems market is expected to continue growing as advancements in technology, increasing surgical expertise, and expanding applications drive adoption. The focus on minimally invasive procedures, improved patient outcomes, and the demand for precision and efficiency in surgeries contribute to the market's expansion.
Anexclusive analysis of all key geographical regions is included in the report which determines the potential opportunities in these regions.
Detailed information about the attributes which are generating growth in the herpes simplex virus treatment market in the forecast period.
Anexactestimation of the herpes simplex virus treatmentmarket share and its contribution to the parent market is provided in the report.
Further profiles of leading competitors and their dynamic strategies are also covered in thestudy.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. COMPONENT: MARKET SIZE & ANALYSIS
5.1. Systems
5.2. Accessories & Instrument
5.3. Services
6. SURGERY TYPE: MARKET SIZE & ANALYSIS
6.1. Prescription
6.2. OTC
7. GEOGRAPHY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. COMPETITIVE LANDSCAPE
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. VENDOR PROFILES
9.1. INTUITIVE SURGICAL, INC.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. GLOBUS MEDICAL, INC.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Johnson & Johnson
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Medtronic Plc
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Siemens AG
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Smith & Nephew
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Stryker Corporation
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Titan Medical Inc
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Transenterix, Inc
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Zimmer Biomet Holdings, Inc.
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. ANALYST OPINION
11. ANNEXURE
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. COMPONENT: MARKET SIZE & ANALYSIS
5.1. Systems
5.2. Accessories & Instrument
5.3. Services
6. SURGERY TYPE: MARKET SIZE & ANALYSIS
6.1. Prescription
6.2. OTC
7. GEOGRAPHY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. COMPETITIVE LANDSCAPE
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. VENDOR PROFILES
9.1. INTUITIVE SURGICAL, INC.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. GLOBUS MEDICAL, INC.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Johnson & Johnson
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Medtronic Plc
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Siemens AG
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Smith & Nephew
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Stryker Corporation
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Titan Medical Inc
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Transenterix, Inc
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Zimmer Biomet Holdings, Inc.
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. ANALYST OPINION
11. ANNEXURE
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2026 (USD BILLION)
TABLE 2. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR SYSTEMS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR ACCESSORIES & INSTRUMENT, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR GYNECOLOGY SURGERY, 2021-2027 (USD BILLION
TABLE 7. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR UROLOGY SURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR NEUROSURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR ORTHOPEDIC SURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR GENERAL SURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. NORTH AMERICA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 12. NORTH AMERICA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 13. NORTH AMERICA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 14. U.SSURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 15. U.SSURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 16. CANADASURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 17. CANADASURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 18. EUROPESURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 19. EUROPESURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 20. EUROPESURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 21. GERMANY ACTINIC KERATOSI TREATMENT MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 22. GERMANY SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 23. U.K SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 24. U.K SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 25. FRANCE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 26. FRANCE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 27. ITALY SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 28. ITALY SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 29. SPAIN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 30. SPAIN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 31. ROE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 32. ROE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 33. ASIA PACIFC SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 34. ASIA PACIFC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 35. ASIA PACIFC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 36. CHINA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 37. CHINA SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 38. INDIA SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 39. INDIA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 40. JAPAN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 41. JAPAN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 42. REST OF APAC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 43. REST OF APAC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 44. REST OF WORLD SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 45. REST OF WORLD SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 46. INTUITIVE SURGICAL, INC: FINANCIALS
TABLE 47. INTUITIVE SURGICAL, INC: PRODUCTS & SERVICES
TABLE 48. INTUITIVE SURGICAL, INC: RECENT DEVELOPMENTS
TABLE 49. GLOBUS MEDICAL, INC: FINANCIALS
TABLE 50. GLOBUS MEDICAL, INC: PRODUCTS & SERVICES
TABLE 51. GLOBUS MEDICAL, INC: RECENT DEVELOPMENTS
TABLE 52. JOHNSON & JOHNSON: FINANCIALS
TABLE 53. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 54. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 55. MEDTRONIC PLC: FINANCIALS
TABLE 56. MEDTRONIC PLC: PRODUCTS & SERVICES
TABLE 57. MEDTRONIC PLC: RECENT DEVELOPMENTS
TABLE 58. SIEMENS AG: FINANCIALS
TABLE 59. SIEMENS AG: PRODUCTS & SERVICES
TABLE 60. SIEMENS AG: RECENT DEVELOPMENTS
TABLE 61. SMITH & NEPHEW: FINANCIALS
TABLE 62. SMITH & NEPHEW: PRODUCTS & SERVICES
TABLE 63. SMITH & NEPHEW: RECENT DEVELOPMENTS
TABLE 64. STRYKER CORPORATION: FINANCIALS
TABLE 65. STRYKER CORPORATION: PRODUCTS & SERVICES
TABLE 66. STRYKER CORPORATION: RECENT DEVELOPMENTS
TABLE 67. TITAN MEDICAL INC: FINANCIALS
TABLE 68. TITAN MEDICAL INC: PRODUCTS & SERVICES
TABLE 69. TITAN MEDICAL INC: RECENT DEVELOPMENTS
TABLE 70. TRANSENTERIX, INC: FINANCIALS
TABLE 71. TRANSENTERIX, INC: PRODUCTS & SERVICES
TABLE 72. TRANSENTERIX, INC: RECENT DEVELOPMENTS
TABLE 73. ZIMMER BIOMET HOLDINGS, INC: FINANCIALS
TABLE 74. ZIMMER BIOMET HOLDINGS, INC: PRODUCTS & SERVICES
TABLE 75. ZIMMER BIOMET HOLDINGS, INC: RECENT DEVELOPMENTS
TABLE 1. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2026 (USD BILLION)
TABLE 2. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR SYSTEMS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR ACCESSORIES & INSTRUMENT, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR GYNECOLOGY SURGERY, 2021-2027 (USD BILLION
TABLE 7. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR UROLOGY SURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR NEUROSURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR ORTHOPEDIC SURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL SURGICAL ROBOTIC SYSTEMS MARKET VALUE FOR GENERAL SURGERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. NORTH AMERICA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 12. NORTH AMERICA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 13. NORTH AMERICA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 14. U.SSURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 15. U.SSURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 16. CANADASURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 17. CANADASURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 18. EUROPESURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 19. EUROPESURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 20. EUROPESURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 21. GERMANY ACTINIC KERATOSI TREATMENT MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 22. GERMANY SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 23. U.K SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 24. U.K SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 25. FRANCE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 26. FRANCE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 27. ITALY SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 28. ITALY SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 29. SPAIN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 30. SPAIN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 31. ROE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 32. ROE SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 33. ASIA PACIFC SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 34. ASIA PACIFC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 35. ASIA PACIFC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 36. CHINA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 37. CHINA SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 38. INDIA SURGICAL ROBOTIC SYSTEMS MARKETVALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 39. INDIA SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 40. JAPAN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 41. JAPAN SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 42. REST OF APAC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 43. REST OF APAC SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 44. REST OF WORLD SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY COMPONENT, 2021-2027 (USD BILLION)
TABLE 45. REST OF WORLD SURGICAL ROBOTIC SYSTEMS MARKET VALUE, BY SURGERY TYPE, 2021-2027 (USD BILLION)
TABLE 46. INTUITIVE SURGICAL, INC: FINANCIALS
TABLE 47. INTUITIVE SURGICAL, INC: PRODUCTS & SERVICES
TABLE 48. INTUITIVE SURGICAL, INC: RECENT DEVELOPMENTS
TABLE 49. GLOBUS MEDICAL, INC: FINANCIALS
TABLE 50. GLOBUS MEDICAL, INC: PRODUCTS & SERVICES
TABLE 51. GLOBUS MEDICAL, INC: RECENT DEVELOPMENTS
TABLE 52. JOHNSON & JOHNSON: FINANCIALS
TABLE 53. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 54. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 55. MEDTRONIC PLC: FINANCIALS
TABLE 56. MEDTRONIC PLC: PRODUCTS & SERVICES
TABLE 57. MEDTRONIC PLC: RECENT DEVELOPMENTS
TABLE 58. SIEMENS AG: FINANCIALS
TABLE 59. SIEMENS AG: PRODUCTS & SERVICES
TABLE 60. SIEMENS AG: RECENT DEVELOPMENTS
TABLE 61. SMITH & NEPHEW: FINANCIALS
TABLE 62. SMITH & NEPHEW: PRODUCTS & SERVICES
TABLE 63. SMITH & NEPHEW: RECENT DEVELOPMENTS
TABLE 64. STRYKER CORPORATION: FINANCIALS
TABLE 65. STRYKER CORPORATION: PRODUCTS & SERVICES
TABLE 66. STRYKER CORPORATION: RECENT DEVELOPMENTS
TABLE 67. TITAN MEDICAL INC: FINANCIALS
TABLE 68. TITAN MEDICAL INC: PRODUCTS & SERVICES
TABLE 69. TITAN MEDICAL INC: RECENT DEVELOPMENTS
TABLE 70. TRANSENTERIX, INC: FINANCIALS
TABLE 71. TRANSENTERIX, INC: PRODUCTS & SERVICES
TABLE 72. TRANSENTERIX, INC: RECENT DEVELOPMENTS
TABLE 73. ZIMMER BIOMET HOLDINGS, INC: FINANCIALS
TABLE 74. ZIMMER BIOMET HOLDINGS, INC: PRODUCTS & SERVICES
TABLE 75. ZIMMER BIOMET HOLDINGS, INC: RECENT DEVELOPMENTS